(WT) - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US97717P1049
Stock: ETFs, Index Licensing, Advisory
Total Rating 65
Risk 68
Buy Signal 0.32
| Risk 5d forecast | |
|---|---|
| Volatility | 36.8% |
| Relative Tail Risk | -4.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.79 |
| Alpha | 59.36 |
| Character TTM | |
|---|---|
| Beta | 1.297 |
| Beta Downside | 2.462 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.13% |
| CAGR/Max DD | 1.13 |
EPS (Earnings per Share)
Revenue
Description: WT March 03, 2026
WisdomTree, Inc. (NYSE: WT) operates as a global asset manager and exchange-traded fund (ETF) sponsor based in New York. The company structures and manages products across diverse asset classes, including equities, fixed income, currencies, and alternatives. Unlike traditional passive funds that often rely on market capitalization, WisdomTree utilizes a proprietary fundamentally weighted index methodology to select and weight securities based on financial metrics such as dividends or earnings.
In addition to managing its own funds, the company generates revenue by licensing its indexes to third parties and providing investment advisory services. As a constituent of the Asset Management & Custody Banks industry, the firm’s financial performance is heavily influenced by net inflows and the total value of assets under management (AUM). Investors seeking to analyze current capital allocation strategies may find helpful insights on ValueRay.
Headlines to watch out for
- ETF inflows drive asset under management growth
- Market volatility impacts investment advisory fees
- Regulatory changes pose compliance cost risks
- Competition intensifies for ETF market share
- Index licensing revenue diversifies income streams
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 109.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.87 > 1.0 |
| NWC/Revenue: 42.59% < 20% (prev 48.90%; Δ -6.31% < -1%) |
| CFO/TA 0.10 > 3% & CFO 149.5m > Net Income 109.1m |
| Net Debt (644.9m) to EBITDA (172.9m): 3.73 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.3m) vs 12m ago -2.91% < -2% |
| Gross Margin: 67.59% > 18% (prev 0.72%; Δ 6.69k % > 0.5%) |
| Asset Turnover: 38.78% > 50% (prev 41.39%; Δ -2.61% > 0%) |
| Interest Coverage Ratio: 5.54 > 6 (EBITDA TTM 172.9m / Interest Expense TTM 30.4m) |
Altman Z'' 2.49
| A: 0.14 (Total Current Assets 492.4m - Total Current Liabilities 282.1m) / Total Assets 1.51b |
| B: 0.15 (Retained Earnings 220.8m / Total Assets 1.51b) |
| C: 0.13 (EBIT TTM 168.5m / Avg Total Assets 1.27b) |
| D: 0.20 (Book Value of Equity 224.4m / Total Liabilities 1.10b) |
| Altman-Z'' Score: 2.49 = A |
Beneish M -2.70
| DSRI: 1.24 (Receivables 64.5m/44.9m, Revenue 493.8m/427.7m) |
| GMI: 1.06 (GM 67.59% / 71.65%) |
| AQI: 0.97 (AQ_t 0.67 / AQ_t-1 0.69) |
| SGI: 1.15 (Revenue 493.8m / 427.7m) |
| TATA: -0.03 (NI 109.1m - CFO 149.5m) / TA 1.51b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of WT shares?
As of March 12, 2026, the stock is trading at USD 15.67 with a total of 2,023,772 shares traded.
Over the past week, the price has changed by -10.46%, over one month by -2.43%, over three months by +34.39% and over the past year by +81.58%.
Over the past week, the price has changed by -10.46%, over one month by -2.43%, over three months by +34.39% and over the past year by +81.58%.
Is WT a buy, sell or hold?
has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy WT.
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the WT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19 | 21.5% |
| Analysts Target Price | 19 | 21.5% |
WT Fundamental Data Overview March 11, 2026
P/E Trailing = 22.12
P/E Forward = 19.3424
P/S = 4.7583
P/B = 5.6897
P/EG = 1.5379
Revenue TTM = 493.8m USD
EBIT TTM = 168.5m USD
EBITDA TTM = 172.9m USD
Long Term Debt = 804.2m USD (from longTermDebt, last quarter)
Short Term Debt = 152.8m USD (from shortTermDebt, last quarter)
Debt = 956.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (2.35b + Debt 956.6m - CCE 418.8m)
Interest Coverage Ratio = 5.54 (Ebit TTM 168.5m / Interest Expense TTM 30.4m)
EV/FCF = 19.35x (Enterprise Value 2.89b / FCF TTM 149.2m)
FCF Yield = 5.17% (FCF TTM 149.2m / Enterprise Value 2.89b)
FCF Margin = 30.23% (FCF TTM 149.2m / Revenue TTM 493.8m)
Net Margin = 22.10% (Net Income TTM 109.1m / Revenue TTM 493.8m)
Gross Margin = 67.59% ((Revenue TTM 493.8m - Cost of Revenue TTM 160.0m) / Revenue TTM)
Gross Margin QoQ = 74.72% (prev 55.31%)
Tobins Q-Ratio = 1.91 (Enterprise Value 2.89b / Total Assets 1.51b)
Interest Expense / Debt = 1.15% (Interest Expense 11.0m / Debt 956.6m)
Taxrate = 20.68% (10.4m / 50.5m)
NOPAT = 133.6m (EBIT 168.5m * (1 - 20.68%))
Current Ratio = 1.75 (Total Current Assets 492.4m / Total Current Liabilities 282.1m)
Debt / Equity = 2.31 (Debt 956.6m / totalStockholderEquity, last quarter 413.7m)
Debt / EBITDA = 3.73 (Net Debt 644.9m / EBITDA 172.9m)
Debt / FCF = 4.32 (Net Debt 644.9m / FCF TTM 149.2m)
Total Stockholder Equity = 412.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.57% (Net Income 109.1m / Total Assets 1.51b)
RoE = 26.49% (Net Income TTM 109.1m / Total Stockholder Equity 412.0m)
RoCE = 13.85% (EBIT 168.5m / Capital Employed (Equity 412.0m + L.T.Debt 804.2m))
RoIC = 11.67% (NOPAT 133.6m / Invested Capital 1.15b)
WACC = 7.81% (E(2.35b)/V(3.31b) * Re(10.62%) + D(956.6m)/V(3.31b) * Rd(1.15%) * (1-Tc(0.21)))
Discount Rate = 10.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.64%
[DCF] Terminal Value 81.87% ; FCFF base≈133.9m ; Y1≈165.2m ; Y5≈281.4m
[DCF] Fair Price = 30.35 (EV 4.94b - Net Debt 644.9m = Equity 4.30b / Shares 141.6m; r=7.81% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.11 | EPS CAGR: 36.62% | SUE: 4.0 | # QB: 2
Revenue Correlation: 95.79 | Revenue CAGR: 18.36% | SUE: 2.30 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.28 | Chg7d=-0.002 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=1.11 | Chg7d=-0.010 | Chg30d=-0.019 | Revisions Net=-1 | Growth EPS=+29.6% | Growth Revenue=+31.4%
EPS next Year (2027-12-31): EPS=1.21 | Chg7d=+0.058 | Chg30d=+0.109 | Revisions Net=+3 | Growth EPS=+8.7% | Growth Revenue=+8.1%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 10.6% - Earnings Yield 4.5%)
[Growth] Growth Spread = +37.9% (Analyst 44.0% - Implied 6.1%)
P/E Forward = 19.3424
P/S = 4.7583
P/B = 5.6897
P/EG = 1.5379
Revenue TTM = 493.8m USD
EBIT TTM = 168.5m USD
EBITDA TTM = 172.9m USD
Long Term Debt = 804.2m USD (from longTermDebt, last quarter)
Short Term Debt = 152.8m USD (from shortTermDebt, last quarter)
Debt = 956.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (2.35b + Debt 956.6m - CCE 418.8m)
Interest Coverage Ratio = 5.54 (Ebit TTM 168.5m / Interest Expense TTM 30.4m)
EV/FCF = 19.35x (Enterprise Value 2.89b / FCF TTM 149.2m)
FCF Yield = 5.17% (FCF TTM 149.2m / Enterprise Value 2.89b)
FCF Margin = 30.23% (FCF TTM 149.2m / Revenue TTM 493.8m)
Net Margin = 22.10% (Net Income TTM 109.1m / Revenue TTM 493.8m)
Gross Margin = 67.59% ((Revenue TTM 493.8m - Cost of Revenue TTM 160.0m) / Revenue TTM)
Gross Margin QoQ = 74.72% (prev 55.31%)
Tobins Q-Ratio = 1.91 (Enterprise Value 2.89b / Total Assets 1.51b)
Interest Expense / Debt = 1.15% (Interest Expense 11.0m / Debt 956.6m)
Taxrate = 20.68% (10.4m / 50.5m)
NOPAT = 133.6m (EBIT 168.5m * (1 - 20.68%))
Current Ratio = 1.75 (Total Current Assets 492.4m / Total Current Liabilities 282.1m)
Debt / Equity = 2.31 (Debt 956.6m / totalStockholderEquity, last quarter 413.7m)
Debt / EBITDA = 3.73 (Net Debt 644.9m / EBITDA 172.9m)
Debt / FCF = 4.32 (Net Debt 644.9m / FCF TTM 149.2m)
Total Stockholder Equity = 412.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.57% (Net Income 109.1m / Total Assets 1.51b)
RoE = 26.49% (Net Income TTM 109.1m / Total Stockholder Equity 412.0m)
RoCE = 13.85% (EBIT 168.5m / Capital Employed (Equity 412.0m + L.T.Debt 804.2m))
RoIC = 11.67% (NOPAT 133.6m / Invested Capital 1.15b)
WACC = 7.81% (E(2.35b)/V(3.31b) * Re(10.62%) + D(956.6m)/V(3.31b) * Rd(1.15%) * (1-Tc(0.21)))
Discount Rate = 10.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.64%
[DCF] Terminal Value 81.87% ; FCFF base≈133.9m ; Y1≈165.2m ; Y5≈281.4m
[DCF] Fair Price = 30.35 (EV 4.94b - Net Debt 644.9m = Equity 4.30b / Shares 141.6m; r=7.81% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.11 | EPS CAGR: 36.62% | SUE: 4.0 | # QB: 2
Revenue Correlation: 95.79 | Revenue CAGR: 18.36% | SUE: 2.30 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.28 | Chg7d=-0.002 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=1.11 | Chg7d=-0.010 | Chg30d=-0.019 | Revisions Net=-1 | Growth EPS=+29.6% | Growth Revenue=+31.4%
EPS next Year (2027-12-31): EPS=1.21 | Chg7d=+0.058 | Chg30d=+0.109 | Revisions Net=+3 | Growth EPS=+8.7% | Growth Revenue=+8.1%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 10.6% - Earnings Yield 4.5%)
[Growth] Growth Spread = +37.9% (Analyst 44.0% - Implied 6.1%)